Hermann‐Josef Gertz

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

Henryk Barthel, Hermann‐Josef Gertz, S. Dresel et al. · The Lancet Neurology · 2011 · 586 citations

Life Sciences, Neurology, Neuroscience +15

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

Willemijn J. Jansen, Olin Janssen, Betty M. Tijms et al. · JAMA Neurology · 2022 · 288 citations · Full text

Medicine, Neurology, Neuroscience +17

Early neurone loss in Alzheimer’s disease: cortical or subcortical?

Thomas Arendt, Martina K. Brückner, Markus Morawski et al. · Acta Neuropathologica Communications · 2015 · 207 citations · Full text

Medicine, Neurology, Neuroscience +14

PET Quantification of ¹⁸F-Florbetaben Binding to β-Amyloid Deposits in Human Brains

Georg Becker, Masanori Ichise, Henryk Barthel et al. · Journal of Nuclear Medicine · 2013 · 129 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study

Henrike Wolf, Gustav Martin Ecke, Simone Bettin et al. · International Journal of Geriatric Psychiatry · 2000 · 124 citations

Medicine, Neurology, Neuroscience +17